Loading...
Loading...
India's ketorolac imports from SPAIN total $299 across 1 shipments from 1 foreign suppliers. SUTPHIN DRUGS INC leads with $299 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include TROIKAA PHARMACEUTICALS LIMITED. This corridor reflects India's pharmaceutical import demand for ketorolac — a concentrated sourcing relationship with select suppliers from SPAIN.

SUTPHIN DRUGS INC is the leading Ketorolac supplier from SPAIN to India, with import value of $299 across 1 shipments. The top 5 suppliers — SUTPHIN DRUGS INC — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SUTPHIN DRUGS INC | $299 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TROIKAA PHARMACEUTICALS LIMITED | $299 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Ketorolac suppliers from SPAIN to India include SUTPHIN DRUGS INC. The leading supplier is SUTPHIN DRUGS INC with import value of $299 USD across 1 shipments. India imported Ketorolac worth $299 USD from SPAIN in total across 1 shipments.
India imported Ketorolac worth $299 USD from SPAIN across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Ketorolac sourced from SPAIN include TROIKAA PHARMACEUTICALS LIMITED. The largest buyer is TROIKAA PHARMACEUTICALS LIMITED with $299 in imports across 1 shipments.
The total value of Ketorolac imports from SPAIN to India is $299 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists